Replies to post #33448 on Biotech Values

[DewDiligence]

>will [Apotex] have to pay bmy?<

Only if Apotex loses at trial next year and, even then, Apotex’s liability is limited to 50% of BMY’s lost profits rather than the 300% liability a generic company normally faces.

Other details of the Plavix case:

1. The Court ordered SNY/BMY to post a $400M bond to cover liabilities pursuant to the preliminary injunction.

2. The Plavix patent trial is now scheduled to start on 1/22/07.

http://yahoo.reuters.com/news/articlehybrid.aspx?storyID=urn:newsml:reuters.com:20060831:MTFH33654_2...

[DewDiligence]

will [Apotex] have to pay BMY?

After more than five years, we can finally close the book on this story.